Rayence
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Rayence makes digital X-ray detectors, sensors that capture X-ray images and convert them into digital pictures used by doctors, dentists, veterinarians, and industrial operators.
Its products cover a full range of applications, from medical and dental imaging to animal care and industrial inspection, and it also develops the image-processing software that works alongside its hardware. Listed on KOSDAQ, Korea's tech-focused stock exchange, the company's detector portfolio spans two core sensor technologies: a thin-film transistor type for still images and large-area sensing, and a CMOS type for high-resolution video imaging.
Summary is AI-generated and may contain errors · figures from DART filings
Rayence has extended into the veterinary market through subsidiaries Wooriyen and Wooriyen Farm, and operates sales and R&D entities in Mexico and the United States.
Rayence in five facts
What does Rayence do?
Rayence makes digital X-ray detectors, sensors that capture X-ray images and convert them into digital pictures used by doctors, dentists, veterinarians, and industrial operators.
Where is Rayence listed and in which sector?
Rayence (Korean name: 레이언스) trades under KRX code 228850 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Health Care sector, Medical Devices.
How large is Rayence?
Its market capitalisation was US$99.8M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Rayence's latest annual revenue and operating profit?
For fiscal year 2025, Rayence reported revenue of US$86.6M, an operating loss of US$3M and a net loss of US$4M, per its annual report on DART (data retrieved from DART on 2026-09-18). Revenue was down 8.6% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-18
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Share cancellation decisionSep 30
- Operating results (consolidated) (preliminary) (fair disclosure)
Rayence filed provisional (unaudited) consolidated results for Q2 2026: revenue of US$25.8M (+25.7% year on year), operating profit of US$1.78M (from a loss a year earlier) and net income of US$1.82M (from a loss a year earlier).
Earnings · Aug 11 - Operating results (consolidated) (preliminary) (fair disclosure)
Rayence filed provisional (unaudited) consolidated results for Q1 2026: revenue of US$24.6M (+34.9% year on year), operating profit of US$2.4M (from a loss a year earlier) and net income of US$3.92M (+2513.3% year on year).
Earnings · May 12 - Cash/in-kind dividend decision
Rayence declared a cash dividend of US$0.20 per share, equal to about 5.7% of the recent share price.
Dividend · Mar 9 - Change of 30% or more in revenue or profit/loss structure (15% for large companies)
Rayence reported consolidated results for FY2025: revenue of US$79.2M (−8.6% year on year), an operating loss of US$2.73M (from a profit a year earlier) and a net loss of US$3.66M (from a profit a year earlier).
Earnings · Feb 20